Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2012 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics, Inc. Announces Pricing of Initial Public Offering and Commencement of Trading

SEATTLE, WA--(Marketwire - Nov 8, 2012) - Atossa Genetics, Inc. (NASDAQ: ATOS) (the "Company") announced today the pricing of its firm commitment, underwritten initial public offering of...
June 04, 2012 14:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Participate in 5th National Breast Centers of Excellence Conference in Dallas, Texas

SEATTLE, WA--(Marketwire - Jun 4, 2012) - Atossa Genetics, Inc., a privately-held health care company focused on the prevention of breast cancer through the commercialization of diagnostic tests...
March 05, 2012 09:48 ET | Source: Atossa Genetics, Inc.

Atossa Genetics' National Reference Laboratory for Breast Health Receives CLIA Certification

SEATTLE, WA--(Marketwire - Mar 5, 2012) - Atossa Genetics, Inc., a private healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can...
February 14, 2012 09:15 ET | Source: Atossa Genetics, Inc.

Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement

SEATTLE, WA--(Marketwire - Feb 14, 2012) - Atossa Genetics, Inc., a privately-held health care company focused on the prevention of breast cancer through the commercialization of diagnostic tests...
December 27, 2011 10:00 ET | Source: Atossa Genetics

Atossa Genetics to Present at Biotech Showcase 2012

SEATTLE, WA--(Marketwire - Dec 27, 2011) - Atossa Genetics, Inc. announced today that Steven C. Quay, M.D., Ph.D., FCAP, Chairman, President & CEO of Atossa Genetics, Inc. and Director of the...
December 06, 2011 08:30 ET | Source: Atossa Genetics

Atossa Genetics Launches ForeCYTE Breast Health Test(SM) for Breast Cancer Risk Assessment

SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...
December 06, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Launch of ArgusCYTE Breast Health Test(SM) for Detection of Circulating Tumor Cells

SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...
October 21, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Sponsor and Participate in the 4th National Conference on Next Generation Comprehensive Breast Centers of Excellence

SEATTLE, WA--(Marketwire - Oct 21, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on offering a comprehensive set of innovative, proprietary breast health evaluation...
August 30, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Present at the 13th Annual Rodman & Renshaw Healthcare Conference

SEATTLE, WA--(Marketwire - Aug 30, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on offering a comprehensive set of innovative, proprietary breast health evaluation...
July 13, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation

SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...